1. Shi, Lang, Zha, Hongchu, Pan, Zhou, Song, Zhixia, Zhu, Jiefu. 2023. DUSP1 protects against ischemic acute kidney injury through stabilizing mtDNA via interaction with JNK. In Cell death & disease, 14, 724. doi:10.1038/s41419-023-06247-4. https://pubmed.ncbi.nlm.nih.gov/37935658/
2. Shen, Jiliang, Zhang, Yaping, Yu, Hong, Shi, Liang, Cai, Xiujun. 2016. Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy. In Cancer medicine, 5, 2061-8. doi:10.1002/cam4.772. https://pubmed.ncbi.nlm.nih.gov/27227569/
3. Ma, JingYuan, Li, ChangYan, Liu, Tao, Liu, XiaoLing, Fan, WenXing. 2022. Identification of Markers for Diagnosis and Treatment of Diabetic Kidney Disease Based on the Ferroptosis and Immune. In Oxidative medicine and cellular longevity, 2022, 9957172. doi:10.1155/2022/9957172. https://pubmed.ncbi.nlm.nih.gov/36466094/
4. Cao, Yang, Du, Yiwei, Jia, Weili, Tao, Kaishan, Yang, Zhaoxu. 2023. Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning. In Frontiers in endocrinology, 14, 1125829. doi:10.3389/fendo.2023.1125829. https://pubmed.ncbi.nlm.nih.gov/36923221/
5. Liu, Yuanhui, Peng, Bi, Chen, Ziqi, Zhang, Jingmin, Yuan, Xianglin. 2024. Pan-cancer transcriptional atlas of minimal residual disease links DUSP1 to chemotherapy persistence. In Experimental hematology & oncology, 13, 42. doi:10.1186/s40164-024-00509-3. https://pubmed.ncbi.nlm.nih.gov/38627863/
6. He, Wenjuan, Liu, Ping, Lei, Quan, Xu, Jun, Liu, Li. 2024. DUSP1 Promotes Osimertinib Drug-Tolerant Persistence by Inhibiting MAPK/ERK Signaling in Non-small Cell Lung Cancer. In Molecular biotechnology, 67, 1256-1268. doi:10.1007/s12033-024-01127-4. https://pubmed.ncbi.nlm.nih.gov/38551790/
智鼠故事 
